Scaling-up the manufacturing of well-characterized mesenchymal stromal cell-derived extracellular vesicles for biomedical applications

The platform established herein could be applied to the production of well-characterized SPC-EVs targeting their biomedical use in different settings (e.g. as drug delivery systems), as well as EVs from other parental cells lines (i.e. dendritic cells) in therapeutic settings as cancer.

Detalhes bibliográficos
Autor principal: Fernandes, Ana (author)
Outros Autores: Rosa, Sara (author), Silva, Ricardo (author), Cunha, Raquel M. S. (author), Fuzeta, Miguel de Almeida (author), Calado, Cecília (author), Carvalho, Carla (author), Cabral, Joaquim M.S. (author), Azevedo, Ana (author), Silva, Cláudia (author)
Formato: conferenceObject
Idioma:eng
Publicado em: 2022
Assuntos:
Stem/progenitor cells-derived extracellular vesicles (SPC-EVs)
Manufacturing platform
Texto completo:http://hdl.handle.net/10400.21/14398
País:Portugal
Oai:oai:repositorio.ipl.pt:10400.21/14398

Texto Completo

http://hdl.handle.net/10400.21/14398

Registros relacionados